Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

HLS

HLS Therapeutics (HLS)

HLS Therapeutics Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:HLS

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
25/04/2024	14h50	PR Newswire (Canada)	HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
09/04/2024	12h30	PR Newswire (Canada)	HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	TSX:HLS	HLS Therapeutics Inc
08/04/2024	12h30	PR Newswire (Canada)	New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	TSX:HLS	HLS Therapeutics Inc
14/03/2024	11h30	PR Newswire (Canada)	HLS Therapeutics Announces Fiscal 2023 Financial Results	TSX:HLS	HLS Therapeutics Inc
29/02/2024	12h30	PR Newswire (Canada)	HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
06/02/2024	12h30	PR Newswire (Canada)	HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan	TSX:HLS	HLS Therapeutics Inc
18/12/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces CFO Departure	TSX:HLS	HLS Therapeutics Inc
14/11/2023	23h12	PR Newswire (Canada)	New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline	TSX:HLS	HLS Therapeutics Inc
09/11/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results and Renewal of Normal Course Issuer Bid	TSX:HLS	HLS Therapeutics Inc
26/10/2023	12h30	PR Newswire (Canada)	HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
06/09/2023	14h30	PR Newswire (Canada)	HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference	TSX:HLS	HLS Therapeutics Inc
14/08/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Updates to its Credit Agreement	TSX:HLS	HLS Therapeutics Inc
10/08/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results	TSX:HLS	HLS Therapeutics Inc
04/08/2023	00h29	PR Newswire (Canada)	HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
22/06/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Updates to its Board of Directors	TSX:HLS	HLS Therapeutics Inc
17/06/2023	00h00	PR Newswire (Canada)	HLS Therapeutics Reports Annual Meeting Results	TSX:HLS	HLS Therapeutics Inc
08/06/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors	TSX:HLS	HLS Therapeutics Inc
11/05/2023	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results	TSX:HLS	HLS Therapeutics Inc
03/05/2023	12h30	PR Newswire (Canada)	HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
21/04/2023	12h30	PR Newswire (Canada)	HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference	TSX:HLS	HLS Therapeutics Inc
17/04/2023	13h00	PR Newswire (Canada)	HLS Therapeutics Announces CEO Transition	TSX:HLS	HLS Therapeutics Inc
16/03/2023	11h30	PR Newswire (Canada)	HLS Therapeutics Announces Q4 and Fiscal 2022 Financial Results	TSX:HLS	HLS Therapeutics Inc
02/03/2023	12h30	PR Newswire (Canada)	HLS Therapeutics to Host Q4 and Fiscal 2022 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
29/11/2022	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Board Appointment	TSX:HLS	HLS Therapeutics Inc
14/11/2022	12h30	PR Newswire (Canada)	HLS Therapeutics to Present at the Stifel Healthcare Conference	TSX:HLS	HLS Therapeutics Inc
10/11/2022	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Q3 Fiscal 2022 Financial Results and Renewal of Normal Course Issuer Bid	TSX:HLS	HLS Therapeutics Inc
07/11/2022	16h30	PR Newswire (Canada)	HLS Therapeutics Highlights Key Data on the Late Breaking RESPECT-EPA Study Presented at the American Heart Association	TSX:HLS	HLS Therapeutics Inc
27/10/2022	12h30	PR Newswire (Canada)	HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call	TSX:HLS	HLS Therapeutics Inc
03/10/2022	12h30	PR Newswire (Canada)	HLS Therapeutics Announces Updates to its Credit Agreement	TSX:HLS	HLS Therapeutics Inc
15/09/2022	12h30	PR Newswire (Canada)	HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on September 22, 2022	TSX:HLS	HLS Therapeutics Inc

Showing the most relevant articles for your search:TSX:HLS

1 2 3 4 5 6 Next >>

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Euro vs Sterling

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen